









市場行情
/
股票
/
nasdaq-holx
/

Hologic Inc

HOLX

74.880USD

+0.120+0.16%

收盤 11/25, 16:00（美東）報價延遲15分鐘

16.67B總市值

29.46本益比TTM



Hologic Inc

74.880

+0.120+0.16%

概覽公司財務分析

概覽

公司

財務

分析

關於 Hologic Inc 公司

Hologic, Inc. 是一家醫療技術公司，主要致力於通過早期檢測和治療改善女性的健康和福祉。該公司是診斷產品、醫學成像系統和外科產品的開發商、製造商和供應商。其部門包括診斷、乳腺健康、婦科外科和骨骼健康。診斷部門提供一系列診斷產品，主要用於輔助篩查和診斷人類疾病。乳腺健康部門提供廣泛的乳腺成像、活檢、乳腺手術和病理解決方案組合。婦科外科部門的產品包括 MyoSure 宮腔鏡組織切除系統、NovaSure 子宮內膜消融系統、Acessa ProVu 腹腔鏡射頻消融系統，以及 CoolSeal 血管封閉產品組合和 JustRight 手術縫合器。骨骼健康部門的產品包括 Horizon DXA 和 Fluoroscan Insight FD 迷你 C 臂。

Hologic Inc簡介



公司代碼HOLX

公司名稱Hologic Inc

上市日期Mar 01, 1990

CEOMr. Stephen P. (Steve) Macmillan

員工數量7063

證券類型Ordinary Share

年結日Mar 01

公司地址250 Campus Drive

城市MARLBOROUGH

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編01752

電話15082632900

網址https://www.hologic.com/

公司代碼HOLX

上市日期Mar 01, 1990

CEOMr. Stephen P. (Steve) Macmillan

Hologic Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

1.41M

+15.48%

Mr. Essex D. Mitchell

Chief Operating Officer

59.18K

+495.99%

Ms. Christiana Stamoulis

Independent Director

47.34K

Mr. Mark Horvath

Division President, Breast and Skeletal Health Solutions

22.79K

+222.98%

Mr. Charles J. Dockendorff, CPA

Independent Director

18.81K

+11.00%

Mr. Brandon Schnittker

Division President, GYN Surgical Solutions

17.60K

+188.84%

Ms. Diana De Walt

Senior Vice President - Human Resources

12.02K

Dr. Ludwig N. Hantson, Ph.D.

Independent Director

9.26K

+25.20%

Ms. Nanaz Mohtashami

Independent Director

4.18K

+80.45%

Ms. Stacey D. Stewart

Independent Director

3.60K

+107.62%

名稱

名稱/職務

職務

持股

持股變動

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

1.41M

+15.48%

Mr. Essex D. Mitchell

Chief Operating Officer

59.18K

+495.99%

Ms. Christiana Stamoulis

Independent Director

47.34K

Mr. Mark Horvath

Division President, Breast and Skeletal Health Solutions

22.79K

+222.98%

Mr. Charles J. Dockendorff, CPA

Independent Director

18.81K

+11.00%

Mr. Brandon Schnittker

Division President, GYN Surgical Solutions

17.60K

+188.84%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Disposables

658.40M

64.31%

Service

208.80M

20.39%

Capital equipment, components and software

152.00M

14.85%

Other

4.60M

0.45%

地區USD

名稱

營收

佔比

United States

760.70M

74.30%

Europe

148.10M

14.47%

Asia

60.30M

5.89%

Rest of World

54.70M

5.34%

業務

地區

業務USD

名稱

營收

佔比

Disposables

658.40M

64.31%

Service

208.80M

20.39%

Capital equipment, components and software

152.00M

14.85%

Other

4.60M

0.45%

股東統計

更新時間: 11月16日週日

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

11.71%

T. Rowe Price Investment Management, Inc.

9.67%

BlackRock Institutional Trust Company, N.A.

5.58%

Manulife Investment Management (North America) Limited

4.69%

State Street Investment Management (US)

4.48%

其他

63.87%

持股股東

佔比

The Vanguard Group, Inc.

11.71%

T. Rowe Price Investment Management, Inc.

9.67%

BlackRock Institutional Trust Company, N.A.

5.58%

Manulife Investment Management (North America) Limited

4.69%

State Street Investment Management (US)

4.48%

其他

63.87%

股東類型

持股股東

佔比

Investment Advisor

57.21%

Investment Advisor/Hedge Fund

28.12%

Hedge Fund

6.68%

Research Firm

2.40%

Pension Fund

2.30%

Bank and Trust

1.78%

Sovereign Wealth Fund

1.26%

Individual Investor

1.03%

Family Office

0.05%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

1587

223.55M

100.44%

-14.31M

2025Q2

1594

230.47M

103.62%

-13.07M

2025Q1

1635

231.71M

103.94%

-14.47M

2024Q4

1617

238.36M

106.18%

-10.05M

2024Q3

1583

240.17M

103.42%

-3.00M

2024Q2

1580

234.77M

100.61%

-6.88M

2024Q1

1595

233.34M

99.37%

-7.61M

2023Q4

1584

235.52M

98.14%

-14.13M

2023Q3

1574

242.15M

98.88%

-13.93M

2023Q2

1583

245.52M

99.77%

-12.39M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

26.70M

12%

-16.89K

-0.06%

Jun 30, 2025

T. Rowe Price Investment Management, Inc.

24.08M

10.83%

+6.39M

+36.15%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

12.95M

5.82%

-509.21K

-3.78%

Jun 30, 2025

Manulife Investment Management (North America) Limited

11.02M

4.96%

+8.23M

+294.34%

Jun 30, 2025

State Street Investment Management (US)

10.10M

4.54%

-14.24K

-0.14%

Jun 30, 2025

Geode Capital Management, L.L.C.

5.83M

2.62%

+97.14K

+1.69%

Jun 30, 2025

Victory Capital Management Inc.

5.50M

2.47%

-1.11M

-16.81%

Jun 30, 2025

Invesco Advisers, Inc.

4.33M

1.95%

+3.88M

+868.40%

Jun 30, 2025

Black Creek Investment Management, Inc.

4.03M

1.81%

+832.44K

+26.05%

Jun 30, 2025

Citadel Advisors LLC

3.71M

1.67%

+3.45M

+1342.24%

Jun 30, 2025

持股ETF



更新時間: 11月6日週四

機構名稱

佔比

First Trust Nasdaq Lux Digi Health Solutions ETF

4.02%

John Hancock Fundamental All Cap Core ETF

3.42%

LeaderShares AlphaFactor Tactical Focused ETF

3.29%

First Trust Indxx Medical Devices ETF

2.21%

Strategas Global Policy Opportunities ETF

2.07%

Formidable ETF

2.01%

iShares U.S. Medical Devices ETF

1.81%

Brandes US Small-Mid Cap Value ETF

1.78%

SPDR S&P Health Care Equipment ETF

1.69%

Invesco S&P 500 Equal Weight Health Care ETF

1.69%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比4.02%

John Hancock Fundamental All Cap Core ETF

佔比3.42%

LeaderShares AlphaFactor Tactical Focused ETF

佔比3.29%

First Trust Indxx Medical Devices ETF

佔比2.21%

Strategas Global Policy Opportunities ETF

佔比2.07%

Formidable ETF

佔比2.01%

iShares U.S. Medical Devices ETF

佔比1.81%

Brandes US Small-Mid Cap Value ETF

佔比1.78%

SPDR S&P Health Care Equipment ETF

佔比1.69%

Invesco S&P 500 Equal Weight Health Care ETF

佔比1.69%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Hologic Inc的前五大股東是誰？



Hologic Inc的前五大股東如下：
The Vanguard Group, Inc.
持有股份：26.70M
佔總股份比例：12.00%。
T. Rowe Price Investment Management, Inc.
持有股份：24.08M
佔總股份比例：10.83%。
BlackRock Institutional Trust Company, N.A.
持有股份：12.95M
佔總股份比例：5.82%。
Manulife Investment Management (North America) Limited
持有股份：11.02M
佔總股份比例：4.96%。
State Street Investment Management (US)
持有股份：10.10M
佔總股份比例：4.54%。